Pharming Group N.V. (PHAR)
NASDAQ·Healthcare·Biotechnology
$16.46
-2.72%
Mkt Cap $1.17B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $111.76M | $106.50M | -4.71% | $0.15 | $0.07 | -53.33% | — | — |
| Q4 2025 Nov 6, 2025 | $98.22M | $97.29M | -0.95% | $0.05 | $0.10 | +100.00% | — | — |
| Q3 2025 Jul 31, 2025 | $80.18M | $110.56M | +37.89% | -$0.10 | $0.06 | +160.00% | — | — |
| Q2 2025 May 8, 2025 | $72.73M | $86.71M | +19.22% | -$0.25 | -$0.22 | +12.00% | — | — |
| Q1 2025 Mar 13, 2025 | $60.93M | $95.96M | +57.50% | $0.07 | $0.05 | -28.57% | — | — |
| Q4 2024 Oct 24, 2024 | $75.58M | $83.84M | +10.93% | $0.01 | -$0.02 | -300.00% | — | — |
| Q3 2024 Aug 1, 2024 | $71.94M | $79.60M | +10.66% | -$0.00 | -$0.01 | -400.00% | — | — |
| Q2 2024 May 8, 2024 | $68.42M | $90.03M | +31.58% | $0.01 | -$0.19 | -2000.00% | — | — |
| Q1 2024 Mar 14, 2024 | $71.83M | $59.71M | -16.86% | $0.05 | -$0.03 | -160.00% | — | — |
| Q4 2023 Oct 26, 2023 | $61.67M | $70.32M | +14.02% | $0.13 | $0.05 | -61.54% | — | — |
| Q3 2023 Aug 3, 2023 | $53.23M | $59.89M | +12.51% | -$0.02 | $0.02 | +200.00% | — | — |
| Q2 2023 May 11, 2023 | $50.34M | $58.84M | +16.87% | -$0.01 | -$0.17 | -1600.00% | — | — |
| Q1 2023 Mar 16, 2023 | $60.25M | $46.25M | -23.24% | $0.01 | -$0.19 | -2000.00% | — | — |
| Q4 2022 Oct 27, 2022 | $53.50M | $52.97M | -1.00% | $0.02 | $0.01 | -48.65% | — | — |
| Q3 2022 Aug 4, 2022 | $51.99M | $52.45M | +0.89% | $0.01 | $0.04 | +300.00% | — | — |
| Q2 2022 May 12, 2022 | $47.65M | $51.86M | +8.85% | -$0.06 | $0.05 | +183.33% | — | — |
| Q1 2022 Mar 17, 2022 | $57.58M | $51.56M | -10.45% | $0.01 | $0.01 | +0.00% | — | — |
| Q3 2021 Aug 9, 2021 | — | $58.33M | — | — | -$0.00 | — | — | — |
| Q2 2021 Apr 7, 2021 | — | $86.13M | — | — | $0.02 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $49.70M | — | — | $0.01 | — | — | — |